The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of shares

9 Apr 2020 07:04

RNS Number : 3385J
Danakali Limited
09 April 2020
 

Announcement

Thursday, 9 April 2020

 

Issue of shares

 

Danakali Limited (ASX: DNK / LSE: DNK) (Danakali, or the Company) confirms that it has issued 20,000 new fully paid shares to an employee, constituting a PDMR, as detailed below, on the vesting of performance rights.

 

A completed Appendix 2A has been lodged together with this announcement and is available for download at: https://www.asx.com.au/asxpdf/20200409/pdf/44gvfc1042mtgt.pdf.

 

Secondary Trading Exemption - s708A Notice

 

Danakali gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Act) of the following:

· The shares were issued without disclosure under Part 6D 2 of the Act;

· This notice is being given under section 708A(5)(e) of the Act;

· As at the date of this notice, the Company has complied with:

The provisions of Chapter 2M of the Act as they apply to the Company; and

Section 674 of the Act; and

· As at the date of this notice, there is no information:

That has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

That investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

o The assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

o The rights and liabilities attaching to the shares.

 

Total voting rights

 

The Company advises that it has, conditional on admission, allotted and issued 20,000 new fully paid ordinary shares of no par value in the Company (Ordinary Shares).

 

Application has been made to the UK Listing Authority for the admission of those 20,000 new Ordinary Shares to the Official List of the UK Listing Authority and to trading on the London Stock Exchange's Main Market for listed securities and it is expected that dealings will commence on 16 April 2020. The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares in issue.

 

Following admission, the Company will have in issue a total of 318,741,306 Ordinary Shares. The Company does not hold any Ordinary Shares in treasury.

 

Therefore, the total number of voting rights in the Company is 318,741,306 which may be used by shareholders or other persons as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

 

Notification of PDMR transaction

 

The Company has received notification from a person discharging managerial responsibilities (PDMR) with respect to 20,000 fully paid ordinary shares issued by the Company on the vesting of performance rights.

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Tony Harrington

2

 

Reason for the notification

a)

 

Position/status

 

PDMR (Project Director)

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

 

Name

Danakali Limited

b)

 

LEI

5493004SQ5E5Q6VRT472

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Fully paid ordinary shares

 

Identification code

AU000000DNK9

b)

 

Nature of the transaction

 

Award of shares on the vesting of performance rights

 

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

20,000

 

d)

Aggregated information

- Aggregated volume

- Price

- Total

 

N/A

e)

 

Date of the transaction

 

8 April 2020

f)

Place of the transaction

 

Outside a trading venue

 

For more information, please contact:

 

Danakali

 

Niels Wage

Chief Executive Officer

+61 8 6189 8635

Todd Romaine

Chief Sustainability Officer

+1 (604) 365 5999

 

Corporate Broker - Numis Securities

 

UK IR/PR - Instinctif Partners

John Prior / James Black / Paul Gillam

+44 (0)20 7260 1000

Mark Garraway / Sarah Hourahane / Dinara Shikhametova

danakali@instinctif.com

+44 (0)207 457 2020

 

Announcement authorised for release by the Company Secretary of Danakali.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKKCBKABKKKQK
Date   Source Headline
22nd May 20209:00 amRNSAppendix 3Ys
21st May 20207:00 amRNSColluli SOP Project Update
15th May 20209:00 amRNSAppendix 3Y
13th May 20207:00 amRNSNotification of PDMR transactions
13th May 20207:00 amRNSAppendix 3Y
11th May 20209:00 amRNSReport on Payments to Governments
7th May 20207:00 amRNSNotification of PDMR transaction
5th May 20207:57 amRNSNotification of PDMR and PCA transactions
5th May 20207:54 amRNSChange of Director’s Interest Notice
1st May 20207:00 amRNSTotal Voting Rights and Capital
30th Apr 20209:39 amRNSRelease of 2019 Annual Report
30th Apr 20207:00 amRNSQ1 2020 Quarterly Report
28th Apr 20208:44 amRNSInitial Director’s Interest Notice
28th Apr 20208:42 amRNSInitial Director’s Interest Notice
23rd Apr 20207:04 amRNSDanakali appoints two directors from AFC
9th Apr 20207:04 amRNSIssue of shares
1st Apr 20207:00 amRNSTotal Voting Rights and Capital
31st Mar 20207:52 amRNSRelease of 2019 Financial Report
31st Mar 20207:00 amRNSCovid-19 and financing update
3rd Mar 20207:00 amRNSDanakali – Colluli SOP Project update
2nd Mar 20207:00 amRNSTotal Voting Rights and Capital
21st Feb 20207:00 amRNSDirector/PDMR Shareholding
21st Feb 20207:00 amRNSChange of Director’s Interest Notice
20th Feb 20207:00 amRNSNotification of PDMR transaction
20th Feb 20207:00 amRNSChange of Director's Interest Notice
20th Feb 20207:00 amRNSNotification of PDMR transaction
20th Feb 20207:00 amRNSChange of Director’s Interest Notice
4th Feb 20207:00 amRNSTotal voting rights and capital
3rd Feb 20207:00 amRNSDanakali investment case - African Mining Indaba
30th Jan 20207:00 amRNSQuarterly Report and Appendix 5B
29th Jan 20207:10 amRNSIssue of shares
29th Jan 20207:00 amRNSAppointment of Chief Sustainability Officer
28th Jan 20207:00 amRNSColluli Update - EPCM Phase 1 commenced
16th Jan 20207:00 amRNSIssue of Shares
6th Jan 20207:00 amRNSTotal voting rights and capital
23rd Dec 20197:00 amRNSUS$200M senior debt documentation executed
20th Dec 20197:00 amRNSNotice to Proceed issued to DRA Global
19th Dec 20197:00 amRNSEMW confirmed as preferred Mining Contractor
18th Dec 201912:15 pmRNSTR-1: Notification of Major Holdings
17th Dec 20197:00 amRNSs708A Notice
10th Dec 20197:01 amRNSIssue of Shares & Appendix 2A
10th Dec 20197:00 amRNSFirst tranche of AFC's strategic equity investment
5th Dec 20197:00 amRNSDanakali welcomes Eritrea's membership in AFC
3rd Dec 20197:05 amRNSAppendix 3B
3rd Dec 20197:00 amRNSUS$50M strategic investment from AFC
2nd Dec 20197:00 amRNSTotal Voting Rights
1st Nov 20197:00 amRNSTotal Voting Rights
30th Oct 20197:00 amRNSQuarterly Report and Appendix 5B
9th Oct 20197:00 amRNSIssue of Shares and Appendix 3B
1st Oct 20197:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.